Today, Canopy Growth Corporation (OTC:TWMJF) (TSX:CGC) reported their second quarter fiscal 2017 financial results. Highlights of the results include:
"Second Quarter Fiscal 2017 Highlights
Revenue of $8.5 million; a 22% increase over first quarter fiscal year 2017 and 245% over the three-month period ended September 30, 2015
Over one metric ton sold in the quarter, specifically 1,169 kilograms and kilogram equivalents, representing an increase of 19% over first quarter fiscal year 2017 and an increase of 267% over the second quarter fiscal year 2016
Harvested 1,711 kilograms during the second quarter ended September 30, 2016
Net income for the quarter ended September 30, 2016 was $5.4 million, including a non-cash unrealized gain on changes in the fair value of biological assets of $16.1 million, compared to net income of $3.9 million in same period last year, including a non-cash unrealized gain on the change in fair value of biological assets totaling $12.5 million
Expenses in the quarter included initial costs to establish Brazil amounting to $0.3 million and related legal expenses of $0.6 million, and $0.3 million related to uplisting to the TSX
Over 24,400 registered patients at September 30, 2016
Listed common shares on the Toronto Stock Exchange
Exported Tweed-branded medical cannabis for sale to German patients for the first time
Starting with Lemon Skunk available for sale, Tweed launched DNA Certified products, coming with a seal of approval from the world’s most decorated cannabis breeders
Opened a world-class, first-of-its-kind in Canada, cannabis breeding facility
Announced partnership with related-party Delivra Inc. to supply Tweed and Bedrocan Canada with cannabis-infused topical product formulations
Closed bought deal financing that raised gross proceeds of $34.5 million
$45.4 million in cash and cash equivalents at quarter end"
For the full press release and financial results, click here.
Never miss a marijuana stock update. Subscribe to The Daily Marijuana Observer newsletter.